Home - Blank Rome LLP

Register to receive insights and analyses on breaking news and trends across varying industries.
<a class="link-primary mt-4" href="/subscribe">Subscribe</a>

Philadelphia, PA

New York, NY

Wilmington, DE

Cincinnati, OH

Princeton, NJ

Los Angeles, CA

Houston, TX

Tampa, FL

Shanghai

South Florida

Pittsburgh, PA

Washington, D.C.

Chicago, IL

Orange County, CA

Dallas, TX

Boston, MA

Main

Leslie Marlow has more than 35 years of experience advising her clients on complex securities transactions, financings, mergers and acquisitions, and other general corporate matters. As a leading corporate and securities attorney, Leslie has represented numerous public and private companies as well as investors, underwriters, and placement agents. She has particular experience representing both issuers and underwriters engaged in public and private securities offerings, including: <ul><li>Initial public offerings (“IPOs”) and follow-on public offerings</li><li>PIPEs and registered direct offerings (“RDOs”)</li><li>At-the-market offerings (“ATMs”)</li><li>Private placements</li><li>Preferred stock offerings</li><li>Rights offerings</li><li>Uplistings </li><li>Venture capital and private equity funding transactions</li></ul>A large part of Leslie’s practice involves providing counsel with respect to ongoing regulatory matters (including compliance with the SEC, NYSE, NYSE American, and Nasdaq laws and regulations) as well as aiding with compliance with securities laws, including being actively involved in the preparation of proxy statements and quarterly and annual securities reporting documents, such as 10K and 10Q reports. Leslie also provides her clients with comprehensive support across their life cycle and acts as a key strategist for their financings and acquisitions as well as managing their day-to-day needs, often filling the role of general counsel and aiding with general contract drafting and negotiation, licenses, master service agreements, and board meetings. In the mergers and acquisitions area, Leslie has represented both buyers and sellers of businesses in a variety of industries.

core/freeform

New York

Investment Management

Private Equity

Venture Capital

Life Sciences

Private Funds

The New Capital Formation Playbook: Navigating Listing Changes and Unlocking Alternative Paths to Market

Blank Rome Represents iBio in $26 Million Private Placement

Blank Rome Represents Quoin Pharmaceuticals in Connection with Private Placement Financing

Blank Rome Represents iBio, Inc. in Connection with Closing of $50 Million Public Offering

Figma Aims at $16.4 Billion Valuation as Tech IPOs Bounce Back

Get IPO-Ready | Preparing Your Company for a Successful Transaction

Emerging Companies

Mergers & Acquisitions

Capital Markets

Corporate Governance

SPACs

Corporate

Finance

Environmental, Social, and Governance (“ESG”)

<ul>
<li>Counsel to a Nasdaq-listed developer of oncology product candidates, involving:
<ul>
<li>$21 million registered direct offering</li>
<li>$10 million PIPE</li>
<li>$60 million ATM</li>
</ul>
</li>
<li>Counsel to a NYSE American-listed company, with $70 million raised off its ATM offering.</li>
<li>Counsel to a Nasdaq-listed developer of oncology product candidates, with more than $100 million raised off its ATM.</li>
<li>Counsel on IPOs of life sciences companies and companies engaged in boat manufacturing.</li>
<li>Counsel on follow-on public offerings, ATMs, equity lines, and registered direct offerings for companies engaged in life sciences, gaming, technology, direct selling, coffee manufacturing, residential and commercial construction, clothing design, and real estate, in connection with their respective securities offerings.</li>
<li>Counsel to a private issuer engaged in the life sciences industry in a $20 million Series A Preferred Stock round and a $125 million Series B Preferred Stock round.</li>
<li>Counsel to a private manufacturer of energy drinks in a $16 million Convertible Note Purchase financing. </li>
<li>Counsel to a private company in the gene therapy field, in connection with a $21 million Series A financing round. </li>
<li>Counsel to underwriters, placement agents, dealer managers, and agents, in connection with numerous IPOs, follow-on offerings, including common stock and preferred stock offerings, ATMs, and registered direct offerings.</li>
<li>Counsel to Nasdaq company acquisition of a company with commercial stage drug products.</li>
<li>Counsel to NYSE-American company acquisition of a company engaged in research and development with upfront payments and CVRs valued at approximately $70 million.</li>
<li>Counsel to licensors, licensees, and sublicensees on licensing and sublicensing transactions.</li>
<li>Counsel on uplistings of OTC companies.</li>
<li>Counsel to REIT on a $37 million rights offering.</li>
<li>Counsel to a $20 million private sale of a company involved in the trucking business.</li>
<li>Counsel to various micro-cap and mid-cap Nasdaq- and NYSE-listed companies in connection with securities law and general corporate and corporate governance matters, including the preparation of registration statements, annual reports, quarterly reports, current reports on Form 8-K, proxy statements, annual meetings, and Section 16 filings. Also report compliance under the Exchange Act and Nasdaq and NYSE listing standards.</li>
<li>Counsel to a reinsurance company for a $51 million private equity investment in preferred stock. </li>
<li>Counsel to more than $100 million in structured debt financings.</li>
</ul>

Leslie Marlow

Leslie Marlow

Offices

Stay Connected

Slide Menu

Slide Search

Offices

Stay Connected